1. Home
  2. SNY
  3. SNY News

Latest Sanofi ADS (SNY) News on June 1, 2025

SNY

Morningstar Research

a day ago

Analyst Report: Sanofi

Regeneron stock sinks over trial data for smoker's lungs drug
SNY

Yahoo Finance Video

a day ago

Regeneron stock sinks over trial data for smoker's lungs drug

SNY

MT Newswires

a day ago

Top Midday Decliners

SNY

MT Newswires

2 days ago

Sector Update: Health Care Stocks Rise in Afternoon Trading

Top Stock Movers Now: Regeneron, Ulta Beauty, Cooper, and More
SNY

Investopedia

2 days ago

Top Stock Movers Now: Regeneron, Ulta Beauty, Cooper, and More

COPD Drug Developed by Regeneron, Sanofi Fails Key Test
SNY

Investopedia

2 days ago

COPD Drug Developed by Regeneron, Sanofi Fails Key Test

Regeneron, SNY Report Mixed Results From Late-Stage COPD Studies
SNY

Zacks

2 days ago

Regeneron, SNY Report Mixed Results From Late-Stage COPD Studies

Regeneron Stock Plunges. Why a Drug Trial Missed the Mark.
SNY

Barrons.com

2 days ago

Regeneron Stock Plunges. Why a Drug Trial Missed the Mark.

SNY

MT Newswires

2 days ago

Sector Update: Health Care Stocks Fall Pre-Bell Friday

Regeneron Pharmaceuticals Crashes 12% On A Surprise Sanofi-Tied Failure
SNY

Investor's Business Daily

2 days ago

Regeneron Pharmaceuticals Crashes 12% On A Surprise Sanofi-Tied Failure

SNY

MT Newswires

2 days ago

Sector Update: Health Care

Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data
SNY

Benzinga

2 days ago

Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data

Stocks to Watch Friday: Dell, Costco, Ulta, Regeneron
SNY

The Wall Street Journal

2 days ago

Stocks to Watch Friday: Dell, Costco, Ulta, Regeneron

SNY

MT Newswires

2 days ago

Update: Sanofi, Regeneron Pharmaceuticals Report Mixed Results From 2 Phase 3 Trials of Itepekimab

Regeneron shares slide on mixed trial data for smoker's lung drug
SNY

Reuters

2 days ago

Regeneron shares slide on mixed trial data for smoker's lung drug

Sanofi, Regeneron Respiratory Drug Delivers Mixed Results in Key Trials
SNY

The Wall Street Journal

2 days ago

Sanofi, Regeneron Respiratory Drug Delivers Mixed Results in Key Trials

Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs
SNY

GlobeNewswire

3 days ago

Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs

Sanofi: New Anthem from Girl Band Raises Awareness of Type 1 Diabetes After Research Highlights Silent Struggle
SNY

PR Newswire

3 days ago

Sanofi: New Anthem from Girl Band Raises Awareness of Type 1 Diabetes After Research Highlights Silent Struggle

Sanofi (SNY)’s MenQuadfi Becomes First MenACWY Vaccine Approved for Ages 6 Weeks and Up
SNY

Insider Monkey

4 days ago

Sanofi (SNY)’s MenQuadfi Becomes First MenACWY Vaccine Approved for Ages 6 Weeks and Up

Press Release: Sanofi completes acquisition of DR-0201
SNY

GlobeNewswire

5 days ago

Press Release: Sanofi completes acquisition of DR-0201

Pharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & More
SNY

Zacks

9 days ago

Pharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & More

SNY

MT Newswires

9 days ago

Sanofi Opens New Offices in New Jersey

Vigil Neuroscience to be acquired by Sanofi for $8.00 per share
SNY

TipRanks

9 days ago

Vigil Neuroscience to be acquired by Sanofi for $8.00 per share

SNY

PR Newswire

9 days ago

Sanofi opens new, $130 million NJ offices in Morristown, showcasing innovative, modern design and strengthening US presence

SNY

MT Newswires

10 days ago

Top Midday Gainers

Sanofi buys Vigil Neuroscience for $470m in Alzheimer’s push
SNY

Pharmaceutical Technology

10 days ago

Sanofi buys Vigil Neuroscience for $470m in Alzheimer’s push

SNY

MT Newswires

10 days ago

European Equities Close Lower in Thursday Trading; Eurozone Business Activity Swings to Contraction

Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi
SNY

Investopedia

10 days ago

Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi

Sanofi (ENXTPA:SAN) Partners With Viz.ai To Enhance AI Solutions For COPD Management
SNY

Simply Wall St.

12 days ago

Sanofi (ENXTPA:SAN) Partners With Viz.ai To Enhance AI Solutions For COPD Management

ATS 2025: Sanofi and Regeneron to launch new AIM4 trial for personalised asthma care
SNY

Pharmaceutical Technology

12 days ago

ATS 2025: Sanofi and Regeneron to launch new AIM4 trial for personalised asthma care

Novavax Shares Jump 17% FDA Grants Full Approval to COVID Vaccine
SNY

GuruFocus.com

12 days ago

Novavax Shares Jump 17% FDA Grants Full Approval to COVID Vaccine

Power of collaboration more pertinent than ever says pharma experts
SNY

Pharmaceutical Technology

13 days ago

Power of collaboration more pertinent than ever says pharma experts

Novavax Secures FDA Approval for COVID-19 Vaccine
SNY

MT Newswires

13 days ago

Novavax Secures FDA Approval for COVID-19 Vaccine

NVAX Stock Surges on Securing FDA Approval for COVID-19 Vaccine
SNY

Zacks

13 days ago

NVAX Stock Surges on Securing FDA Approval for COVID-19 Vaccine

Novavax Stock Soars on FDA Approval for New COVID-19 Vaccine
SNY

Investopedia

13 days ago

Novavax Stock Soars on FDA Approval for New COVID-19 Vaccine

Judge shuts down drugmakers’ 340B rebate plans, for now
SNY

Healthcare Dive

13 days ago

Judge shuts down drugmakers’ 340B rebate plans, for now

Sanofi: Information concerning the total number of voting rights and shares - April 2025
SNY

GlobeNewswire

17 days ago

Sanofi: Information concerning the total number of voting rights and shares - April 2025

French finance minister criticises Sanofi's $20 billion USA investment decision
SNY

Reuters

17 days ago

French finance minister criticises Sanofi's $20 billion USA investment decision

Sanofi commits ‘at least $20bn’ to US manufacturing through 2030
SNY

Pharmaceutical Technology

17 days ago

Sanofi commits ‘at least $20bn’ to US manufacturing through 2030

Sanofi to pour more than $20B into US drug research and manufacturing
SNY

BioPharma Dive

17 days ago

Sanofi to pour more than $20B into US drug research and manufacturing

SNY

MT Newswires

18 days ago

Sanofi to Invest at Least $20 Billion in US Through 2030

France's Sanofi to invest at least $20 billion in US through 2030
SNY

Reuters

18 days ago

France's Sanofi to invest at least $20 billion in US through 2030

Sanofi to invest at least $20 billion in the US through 2030, growing investments in science and expanding domestic manufacturing
SNY

PR Newswire

18 days ago

Sanofi to invest at least $20 billion in the US through 2030, growing investments in science and expanding domestic manufacturing

Sanofi (SNY): A Bull Case Theory
SNY

Insider Monkey

19 days ago

Sanofi (SNY): A Bull Case Theory

SNY

Morningstar Research

19 days ago

Analyst Report: Sanofi

SNY

MT Newswires

20 days ago

Bristol-Myers Squibb, Sanofi Enter $700 Million Settlement With Hawaii in Plavix Lawsuit

Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower
SNY

Bloomberg

20 days ago

Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower

Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices
SNY

Bloomberg

20 days ago

Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices

SNY

Associated Press Finance

22 days ago

Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit

NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up
SNY

Zacks

23 days ago

NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up

COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why
SNY

Benzinga

24 days ago

COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why

Sanofi exec tells biotechs not to scrimp on clinical trial design
SNY

Clinical Trials Arena

24 days ago

Sanofi exec tells biotechs not to scrimp on clinical trial design

Novavax to Report First-Quarter Earnings: Is a Beat in Store?
SNY

Zacks

a month ago

Novavax to Report First-Quarter Earnings: Is a Beat in Store?

European Firms Fare Better Than Feared Through Early Trade Pain
SNY

Bloomberg

a month ago

European Firms Fare Better Than Feared Through Early Trade Pain

Sanofi: Information concerning the total number of voting rights and shares - March 2025
SNY

GlobeNewswire

a month ago

Sanofi: Information concerning the total number of voting rights and shares - March 2025

Sanofi (ENXTPA:SAN) Announces €4 Per Share Dividend And New Compensation Committee Chair
SNY

Simply Wall St.

a month ago

Sanofi (ENXTPA:SAN) Announces €4 Per Share Dividend And New Compensation Committee Chair

Sanofi (SNY, Financials) Completes Opella Deal, Creates Consumer Health Leader
SNY

GuruFocus.com

a month ago

Sanofi (SNY, Financials) Completes Opella Deal, Creates Consumer Health Leader

SNY

MT Newswires

a month ago

Sanofi Closes Sale of Controlling Stake in Opella to CD&R

Press Release: Annual General Meeting of April 30, 2025
SNY

GlobeNewswire

a month ago

Press Release: Annual General Meeting of April 30, 2025

Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
SNY

GlobeNewswire

a month ago

Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader

SNY

GuruFocus.com

a month ago

Swedish Orphan Biovitrum AB (BIOVF) Q1 2025 Earnings Call Highlights: Strong Haematology Growth ...

Regeneron Stock Falls on Q1 Earnings and Sales Miss, Eylea Sales Down
SNY

Zacks

a month ago

Regeneron Stock Falls on Q1 Earnings and Sales Miss, Eylea Sales Down

Regeneron's first-quarter results miss on lower Eylea demand
SNY

Reuters

a month ago

Regeneron's first-quarter results miss on lower Eylea demand

SNY

Argus Research

a month ago

Analyst Report: Sanofi SA

SNY

Argus Research

a month ago

Market Digest: SNY, CLS, DPZ, GE, DOC, ROP, SAP, TMO, AGNC

Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race
SNY

GlobeNewswire

a month ago

Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race

Private Equity Firms Target Defense Assets Once Seen as Toxic
SNY

Bloomberg

a month ago

Private Equity Firms Target Defense Assets Once Seen as Toxic

Halozyme sues Merck; FDA blames cuts for Vanda delay
SNY

BioPharma Dive

a month ago

Halozyme sues Merck; FDA blames cuts for Vanda delay

Swiss Agree to Tariff Negotiations With Trump Administration
SNY

Bloomberg

a month ago

Swiss Agree to Tariff Negotiations With Trump Administration

Pharma Giant Roche Tops First-Quarter Views; Sanofi's Sales Come In Mixed
SNY

Investor's Business Daily

a month ago

Pharma Giant Roche Tops First-Quarter Views; Sanofi's Sales Come In Mixed

Sanofi axes development of oral TNF inhibitor as monotherapy following Phase II fail
SNY

Clinical Trials Arena

a month ago

Sanofi axes development of oral TNF inhibitor as monotherapy following Phase II fail

French Drugmaker Sanofi Clocks 20% Q1 Profit Growth, Forecasts Strong Rebound In Annual Profit
SNY

Benzinga

a month ago

French Drugmaker Sanofi Clocks 20% Q1 Profit Growth, Forecasts Strong Rebound In Annual Profit

SNY

MT Newswires

a month ago

Sector Update: Health Care Stocks Steady Pre-Bell Thursday

Sanofi Q1 Earnings Top Estimates, Dupixent Drives Sales Growth
SNY

Zacks

a month ago

Sanofi Q1 Earnings Top Estimates, Dupixent Drives Sales Growth

Sanofi stays on course amid tariff turmoil
SNY

BioPharma Dive

a month ago

Sanofi stays on course amid tariff turmoil

SNY

MT Newswires

a month ago

Sanofi's Q1 Earnings, Revenue Rise; 2025 Guidance Confirmed

SNY

MT Newswires

a month ago

Innate Pharma, Sanofi Finalize Investment

Sanofi Sales, Profit Beat Expectations on Higher Demand for Skin, Asthma Drug
SNY

The Wall Street Journal

a month ago

Sanofi Sales, Profit Beat Expectations on Higher Demand for Skin, Asthma Drug

SNY

GlobeNewswire

a month ago

Press Release: Sanofi: strong Q1 performance and 2025 guidance confirmed

SNY

MT Newswires

a month ago

Sanofi to Invest $17.2 Million in Innate Pharma as Part of Review of 2016 License Agreement

European pharma companies push for higher drug prices in EU amid U.S. tariff threats
SNY

Reuters

a month ago

European pharma companies push for higher drug prices in EU amid U.S. tariff threats

Will These 5 Large Drug Maker Stocks Surpass Q1 Earnings Forecast?
SNY

Zacks

a month ago

Will These 5 Large Drug Maker Stocks Surpass Q1 Earnings Forecast?

Sanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria
SNY

Zacks

a month ago

Sanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria

SNY

MT Newswires

a month ago

FDA Approves Dupixent for Chronic Hives in Patients Unresponsive to Antihistamines

Sanofi and Regeneron’s dupilumab approved by FDA for urticaria
SNY

Pharmaceutical Technology

a month ago

Sanofi and Regeneron’s dupilumab approved by FDA for urticaria

Regeneron, Sanofi announce FDA approval of Dupixent for CSU
SNY

TipRanks

a month ago

Regeneron, Sanofi announce FDA approval of Dupixent for CSU

Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria
SNY

GlobeNewswire

a month ago

Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
SNY

GlobeNewswire

a month ago

Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)

Sanofi, Regeneron win FDA nod for Dupixent in chronic hives
SNY

BioPharma Dive

a month ago

Sanofi, Regeneron win FDA nod for Dupixent in chronic hives

SNY

MT Newswires

a month ago

Sanofi, Earendil Labs Sign Licensing Deal for Autoimmune, Inflammatory Bowel Disease Treatments

Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback
SNY

Zacks

a month ago

Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback

Sanofi licenses immune disease drugs from startup Earendil
SNY

BioPharma Dive

a month ago

Sanofi licenses immune disease drugs from startup Earendil

Sanofi Advances Mid-to-Late-Stage Pipeline in Respiratory Indications
SNY

Zacks

2 months ago

Sanofi Advances Mid-to-Late-Stage Pipeline in Respiratory Indications

Chrissy Teigen - author, entrepreneur, mom to young son with type 1 diabetes - joins Sanofi's Screen For Type 1 movement
SNY

PR Newswire

2 months ago

Chrissy Teigen - author, entrepreneur, mom to young son with type 1 diabetes - joins Sanofi's Screen For Type 1 movement

Tariff wars to hit popular US-made drugs in China, regulator data shows
SNY

Reuters

2 months ago

Tariff wars to hit popular US-made drugs in China, regulator data shows

Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD
SNY

GlobeNewswire

2 months ago

Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD

Why You Shouldn't Bet Against Sanofi (SNY) Stock
SNY

Zacks

2 months ago

Why You Shouldn't Bet Against Sanofi (SNY) Stock

AAN 2025: Sanofi’s tolebrutinib likely to be first BTK inhibitor for the treatment of MS
SNY

Clinical Trials Arena

2 months ago

AAN 2025: Sanofi’s tolebrutinib likely to be first BTK inhibitor for the treatment of MS

Trump Says Pharmaceutical Tariffs Coming ‘Very Shortly’
SNY

Bloomberg

2 months ago

Trump Says Pharmaceutical Tariffs Coming ‘Very Shortly’

Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
SNY

GlobeNewswire

2 months ago

Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

Share on Social Networks: